| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1746 | 2016 |
| Phase 3 studies comparing brodalumab with ustekinumab in psoriasis M Lebwohl, B Strober, A Menter, K Gordon, J Weglowska, L Puig, K Papp, ... New England Journal of Medicine 373 (14), 1318-1328, 2015 | 838 | 2015 |
| Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer D Sarrazin, MG Le, R Arriagada, G Contesso, F Fontaine, M Spielmann, ... Radiotherapy and Oncology 14 (3), 177-184, 1989 | 766 | 1989 |
| Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities U Veronesi, J Adamus, DC Bandiera, IO Brennhovd, E Caceres, ... Cancer 49 (11), 2420-2430, 1982 | 606 | 1982 |
| Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis KA Papp, A Blauvelt, M Bukhalo, M Gooderham, JG Krueger, JP Lacour, ... New England Journal of Medicine 376 (16), 1551-1560, 2017 | 523 | 2017 |
| Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2) A Wollenberg, A Blauvelt, E Guttman‐Yassky, M Worm, C Lynde, ... British Journal of Dermatology 184 (3), 437-449, 2021 | 418 | 2021 |
| Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials EL Simpson, JP Lacour, L Spelman, R Galimberti, LF Eichenfield, ... British Journal of Dermatology 183 (2), 242-255, 2020 | 396 | 2020 |
| Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE) C Paul, JP Lacour, L Tedremets, K Kreutzer, S Jazayeri, S Adams, ... Journal of the European Academy of Dermatology and Venereology 29 (6), 1082-1090, 2015 | 334 | 2015 |
| Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency H Aubert‐Wastiaux, L Moret, A Le Rhun, AM Fontenoy, JM Nguyen, ... British journal of dermatology 165 (4), 808-814, 2011 | 327 | 2011 |
| Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer J Lacour, M Le, E Caceres, T Koszarowski, U Veronesi, C Hill Cancer 51 (10), 1941-1943, 1983 | 313 | 1983 |
| Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five‐year results of an international cooperative study J Lacour, P Bucalossi, E Cacers, G Jacobelli, T Koszarowski, M Le, ... Cancer 37 (1), 206-214, 1976 | 312 | 1976 |
| Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo T Passeron, N Ostovari, W Zakaria, E Fontas, JC Larrouy, JP Lacour, ... Archives of dermatology 140 (9), 1065-1069, 2004 | 310 | 2004 |
| The burden of chronic spontaneous urticaria is substantial: real‐world evidence from ASSURE‐CSU M Maurer, M Abuzakouk, F Bérard, W Canonica, H Oude Elberink, ... Allergy 72 (12), 2005-2016, 2017 | 306 | 2017 |
| Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised … AMM Eggermont, CU Blank, M Mandalà, GV Long, VG Atkinson, S Dalle, ... The lancet oncology 22 (5), 643-654, 2021 | 290 | 2021 |
| Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. Y Gache, S Chavanas, JP Lacour, G Wiche, K Owaribe, G Meneguzzi, ... The Journal of clinical investigation 97 (10), 2289-2298, 1996 | 285 | 1996 |
| Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS) M Ohanna, S Giuliano, C Bonet, V Imbert, V Hofman, J Zangari, K Bille, ... Genes & development 25 (12), 1245-1261, 2011 | 270 | 2011 |
| The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion N Fenouille, M Tichet, M Dufies, A Pottier, A Mogha, JK Soo, S Rocchi, ... PloS one 7 (7), e40378, 2012 | 243 | 2012 |
| Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling M Amyere, N Revencu, R Helaers, E Pairet, E Baselga, M Cordisco, ... Circulation 136 (11), 1037-1048, 2017 | 238 | 2017 |
| Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms JP Lacour British Journal of Dermatology 146 (s61), 17-19, 2002 | 235 | 2002 |
| Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata E Castela, F Le Duff, C Butori, M Ticchioni, P Hofman, P Bahadoran, ... JAMA dermatology 150 (7), 748-751, 2014 | 234 | 2014 |
Thierry PasseronCHU Nice & INSERM U1065Adresse e-mail validée de chu-nice.fr
